Across TCGA pan-cancer cohorts, LINC01460 Mutation is linked to patient survival in 2 of 34 cancer types, making it a survival-associated LINC01460 data layer compared with 19 for mass-spec protein.

The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where higher LINC01460 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated LINC01460 expression acts as an unfavorable survival marker.

LIHC and UCEC are the cancer types where LINC01460 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LIHC	OS	Median	All	0.144	0.688	.013	9	view →
UCEC	OS	Median	IV	0.231	0.592	.036	6	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: LINC01460 tumor-vs-normal RNA expression · all LINC01460 data types